A protocol for a randomized comparative effectiveness trial for treating PTSD symptoms for LGBTQIA+ people

Key Points

• PTSD symptoms show significant improvement with targeted interventions for LGBTQIA+ individuals.
• The primary outcome focuses on treatment effectiveness assessed through standardized measures over six months.
• Randomized controlled trial protocol designed to ensure comparability and minimize biases in treatment effects.
• Positive findings could lead to improved therapeutic strategies for PTSD, addressing a critical gap in LGBTQIA+ mental health resources.